Selected Publications

Environmental Autoimmunity Group

2008

1. O'Hanlon TP, Rider LG, Schiffenbauer A, Targoff IN, Malley JK, Pandey JP, Miller FW. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis and rheumatism 2008 58(10):3239-3246. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18821675)
2. Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM, Sebring N, O'Hanlon TP, Ruiz-Hidalgo MR, Turner M, Gordon LB, Laborda J, Bauer S, Blackshear PJ, Phil D, Imundo L, Miller FW, Rider LG. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine 2008 87(2):70-86. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18344805)
3. Huber AM, Lachenbruch PA, Dugan EM, Miller FW, Rider LG. Alternative scoring of the Cutaneous Assessment Tool (CAT) in juvenile dermatomyositis: results using an abbreviated format. Arthritis care and research : the official journal of the Arthritis Health Professions Association 2008 59(3):352-356. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18311761)
4. Rider LG, Leschek EW. Does early growth hormone therapy prevent glucocorticoid-associated growth retardation in children with JIA? Commentary on article by Simon et. al.. Nature clinical practice. Rheumatology 2008 4(3):394-395. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18607398)
5. Rider LG, Lachenbruch PA, Isenberg D, Miller FW. Applicability of the paediatric rheumatology international trials organisation disease activity core set for juvenile dermatomyositis: Comment on the article by Ruperto et al.. Arthritis care and research : the official journal of the Arthritis Health Professions Association 2008 59(8):1197-1198. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18668578)

2007

1. Csako G, Costello R, Shamim EA, O'Hanlon TP, Tran A, Clauw D, Williams HJ, Miller FW. Serum proteins and paraproteins in women with silicone implants and connective tissue disease - A case-control study. Arthritis research & therapy 2007 9(5):R95-. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17875216)
2. Gourley, M and Miller, FW. Mechanisms of Disease: Environmental Factors in the Pathogenesis of Rheumatic Disease. Nature Clinical Practice Rheumatology 2007; 3:172-180.
3. Vegosen, L, Weinberg, C, O'Hanlon, T, Targoff, I, Koneru, B, Mamyrova, G, Miller, FW, Rider, L. Seasonal birth patterns suggest a role for perinatal environmental factors in the etiology of subgroups of myositis, Arthritis Rheum. 2007; 56:2729-2739. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17665425)
4. Huber, AM, Dugan, EM, Lachenbruch, PA, Feldman, BM, Perez, MD, Zemel, LS, Lindsley, CB, Rennebohm, RM, Wallace, CA, Passo, MH, Reed, AM, Bowyer, SL, Ballinger, SH, Miller, FW, Rider, LG. The Cutaneous Assessment Tool (CAT): development and reliability in juvenile idiopathic inflammatory myopathy. Rheumatism 2007; 10:1606-1611. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17890275)

2006

1. O'Hanlon, TP, Mercatante-Carrick, D, Targoff, IN, Arnett, FC, Reveille, J, Carrington, M, Gao, X, Oddis, CV, Morel, P, Malley, JD, Malley, K, Shamim, E, Rider, LG, Chanock, SJ, Foster, C, Bunch, T, Blackshear, PJ, Plotz, PH, Love, LA, Miller, FW. Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies. Medicine (Baltimore), 2006;85(2):111-127.
2. Targoff, IN, Mamyrova, G, Trieu, E, Perurena, O, Koneru, B, O'Hanlon, YP, Miller, FW*, Rider, LG*, for the Childhood Myositis Heterogeneity and International Myositis Collaborative Study Groups. A novel autoantibody to a 155 kd protein is associated with dermatomyositis. Arthritis Rheum. 2006; 54:3682-3689 * contributed equally
3. O'Hanlon, TP, Rider, LG, Mamyrova, G, Targoff, IN, Arnett, FC, Reveille, J, Carrington, M, Gao, X, Oddis, CV, Morel, P, Malley, JD, Malley, K, Shamim, E, Chanock, SJ, Foster, C, Bunch, T, Plotz, PH, Love, LA, Miller, FW. HLA Polymorphisms in African Americans with Idiopathic Inflammatory Myopathies: Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies, Arthritis Rheum. 2006; 54:3670-3681.
4. Mamyrova G, O'Hanlon TP, Monroe J, Mercatante Carrick D, Malley J, Adams S, Reed AM, Shamim E, James Newton L, Miller FW, Rider LG, for the Childhood Myositis Heterogeneity Collaborative Study Group. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasian patients, Arthritis Rheum. 2006; 54:3979-3987.
5. Römisch, K, Miller, FW, Dobberstein, B and High, S. Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages, Arthritis Research & Therapy 2006;8(2):R39.

2005

1. Oddis, CV, Rider, LG, Reed, AM, Ruperto, N, Brunner, H, Koneru, B, Feldman, BM, Giannini, EH, and Miller, FW for the International Myositis Assessment and Clinical Studies Group (IMACS). International consensus guidelines for therapeutic trials in the idiopathic inflammatory myopathies, Arthritis Rheum., 2005; 52(9):2607-2615.
2. O'Hanlon, TP, Mercatante-Carrick, D, Arnett, FC, Reveille, J, Carrington, M, Oddis, CV, Morel, P, Malley, JD, Malley, K, Dreyfuss, J, Shamim, E, Rider, LG, Chanock, SJ, Foster, C, Bunch, T, Plotz, PH, Love, LA, Miller, FW. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: Distinct HLA-A, -B, -C, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore) 2005;84(6):338-49.
3. Chung, Y-L, Rider, LG, Bell, JD, Summers, RM, Zemel, LS, Rennebohm, RM, Passo, MH, Hicks, J, Miller, FW, Scott, DL, for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2005;53(4):565-70.
4. Sarkar, K, Weinberg CR, Oddis, CV, Medsger, TA, Plotz, PH, Reveille, JD, Arnett, FC, Targoff, IN, Genth, E, Love, LA, Miller, FW. Seasonal influence in the onset of idiopathic inflammatory myopathies. Arthritis Rheum. 2005;52(8):2433-8.

2004

1. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev. 2004 Aug;3(6):454-63
2. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum. 2004 Jul;50(7):2281-90.
3. Rennebohm RM, Jones K, Huber AM, Ballinger SH, Bowyer SL, Feldman BM, Hicks J, Katona IM, Lindsley CB, Miller FW, Passo MH, Perez MD, Reed AM, Wallace CA, White PH, Zemel LS, Lachenbruch PA, Hayes JR, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum. 2004 Jun 15;51(3):365-70.
4. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004 May;50(5):1595-603.

2003

1. Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 2003 Sep;48(9):2567-72.
2. Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW; International Myositis Collaborative Study Group. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003 Aug;48(8):2285-93.
3. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A, For The Paediatric Rheumatology International Trials Organisation (PRINTO), The Pediatric Rheumatology Collaborative Study Group (PRCSG). Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford). 2003 Jun 27
4. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group. Defining Clinical Improvement in Adult and Juvenile Myositis. J Rheumatol. 2003 Mar;30(3):603-17. Review.
5. Rider LG. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002 Nov;28(4):935-77. Review.

2002

1. Herdon TM, Yuang-Taung J, Solomou EE, Rothwell SW, Gourley MF, Tsokos GC. (2002). Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol. 103: 145-153.
2. O'Hanlon, T.P. and Miller, F.W. (2002). Genomic Organization, Transcriptional Mapping, and Evolutionary Implications of the Human Bi-directional Histidyl-tRNA Synthetase Locus (HARS / HARSL). Biochemical and Biophysical Research Communications 294: 609-614.
3. Shamim, EA, LG Rider, JP Pandey, TP O'Hanlon, LJ Jara, E Samayoa, R Burgos-Vargas, J Vazquez-Mellado, J Alcocer-Varela, M Salazar-Paramo, AG Kutzbach, JD Malley, IN Targoff, I Garcia de la Torre, and FW Miller (2002). Idiopathic Inflammatory Myopathy Phenotypes and Genotypes Differ in Mesoamerican Mestizos and North American Caucasians: Ethnogeographic Influences in the Genetics and Clinical Expression of Myositis. Arthritis Rheum. 46 (7): 1885-1893.

2001

1. Illei, G.G., Austin, HA., Crane, M., Collins L., Gourley, M.F., Yarboro, C.H., Vaughan, E.M., Kuroiwa, T., Danning, C.L., Steinberg, A.D., Klippel, J.H., Balow, J.E., Boumpas, D.T. (2001). Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Int Med. 135:248-257.
2. Miller, FW (2001). Inflammatory Myopathies: Polymyositis, dermatomyositis, and related conditions. In Arthritis and Allied Conditions, A Textbook of Rheumatology, 14th Edition, Lippincott, Williams and Wilkins, Philadelphia, W. Koopman, editor. Chapter 78, 1562-1589 (volume 2).

2000

1. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW and Rider LG (2000). Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 356: 2155-2156.
2. O'Hanlon, T.P., Lawless, O.J., Katzin, W.E., Feng, L.J., and Miller, F.W. (2000). Restricted and Shared Patterns of TCR beta-chain Gene Expression in Silicone Breast Implant Capsules and Remote Sites of Tissue Inflammation. Journal of Autoimmunity 14: 247-257.
3. Miller FW, Hess EV, Clauw DW, Hertzman PA, Pincus T, Silver RM, Mayes MD, Varga J, Medsger TA, and Love LA (2000). Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:243-249.
4. Rider LG, Artlett CM, Foster CB, Ahmed A, Neeman T, Chanock SJ, Jimenez SA and Miller FW (2000). Polymorphisms in the interleukin-1 receptor antagonist VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin ExpImmunology 121:47-52.
5. Rider LG and Targoff IN (2000). Single organ systems and autoimmunity: Muscle Diseases. Textbook of Autoimmune Diseases, ed. R.G. Lahita, N. Chiorazzi, W.H. Reeves. Lippincott- Raven, Philadelphia, PA. Pg 429 - 474.
6. Shamim E, Rider LG, and Miller FW (2000). Genetic risk factors for the idiopathic inflammatory myopathies. Current Opinion Rheumatol. 12: 482-91.

 Back to top